The senior leaders of the Consortium include sixteen individuals: The Director, the Deputy Director, ten Associate Directors, the Consortium Administrator, and three Deputy Associate Directors. The Associate Directors provide oversight and coordination of the Consortium's scientific disciplines of basic sciences, clinical sciences, and public health sciences. They co-direct the oversight and coordination of various Consortium processes, including planning and evaluation, shared resources, membership, and allocation of developmental funds. In addition, they serve as institutional representatives. The three independent institutions in the Consortium have different cultures and locations, so these individuals have a strong communication role to ensure that the members within their institutions are aware of activities and issues of the Consortium. In addition to representing the interests of the Consortium at their institutions, they also represent the interests of their institutions within the Consortium. The Deputy Associate Directors leaders are responsible for scientific planning for the Consortium, formation and management of the Consortium interdisciplinary goals for coordinating internal program review, shared resources review, and review of pilot funding. These functions are accomplished through their leadership of the Consortium Scientific Steering Committee, in which they enlist the help and support of the Consortium program leaders for these activities. The Consortium Administrator is responsible for implementation of the Consortium goals and objectives, and coordination of Consortium and CCSG administrative and management support activities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA015704-39S3
Application #
8719212
Study Section
Subcommittee G - Education (NCI)
Project Start
2013-01-01
Project End
2013-12-31
Budget Start
2013-09-01
Budget End
2013-12-31
Support Year
39
Fiscal Year
2013
Total Cost
$125,000
Indirect Cost
$53,977
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Zhao, Shanshan; Leonardson, Amy; Geybels, Milan S et al. (2018) A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. Prostate :
Greenbaum, Adam M; Green, Damian J; Holmberg, Leona A et al. (2018) Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma. Blood Res 53:223-226
Giraldo, Nicolas A; Nguyen, Peter; Engle, Elizabeth L et al. (2018) Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab. J Immunother Cancer 6:99
DeWitt 3rd, William S; Smith, Anajane; Schoch, Gary et al. (2018) Human T cell receptor occurrence patterns encode immune history, genetic background, and receptor specificity. Elife 7:
Herman, Daniel S; Smith, Christina; Liu, Chang et al. (2018) Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close Homolog. J Mol Diagn 20:512-521
Birnbaum, Jeanette K; Duggan, Catherine; Anderson, Benjamin O et al. (2018) Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study. Lancet Glob Health 6:e885-e893
Partridge, Emma K; Neuhouser, Marian L; Breymeyer, Kara et al. (2018) Comparison of Nutrient Estimates Based on Food Volume versus Weight: Implications for Dietary Assessment Methods. Nutrients 10:
Jia, Deshui; Augert, Arnaud; Kim, Dong-Wook et al. (2018) Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition. Cancer Discov 8:1422-1437
Kuzma, Jessica N; Cromer, Gail; Hagman, Derek K et al. (2018) Consuming glucose-sweetened, not fructose-sweetened, beverages increases fasting insulin in healthy humans. Eur J Clin Nutr :
Neumeyer, Sonja; Banbury, Barbara L; Arndt, Volker et al. (2018) Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. Br J Cancer 118:1639-1647

Showing the most recent 10 out of 1267 publications